Bladder organoids: a step towards personalised cancer therapy?

Affiliations

Editorial

Sreemoti Banerjee et al. Transl Androl Urol. 2019 Jul.

. 2019 Jul;8(Suppl 3):S300-S302.

doi: 10.21037/tau.2019.06.10.

¹ Jack Birch Unit for Molecular Carcinogenesis, Department of Biology, York Biomedical Research Institute, University of York, York, UK.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Mouse and human urothelial cancer organoids: A tool for bladder cancer research.
Mullenders J, de Jongh E, Brousali A, Roosen M, Blom JPA, Begthel H, Korving J, Jonges T, Kranenburg O, Meijer R, Clevers HC. Mullenders J, et al. Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4567-4574. doi: 10.1073/pnas.1803595116. Epub 2019 Feb 20. Proc Natl Acad Sci U S A. 2019. PMID: 30787188 Free PMC article.

1. Masters JR, Hepburn PJ, Walker L, et al. Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial cell lines. Cancer Res 1986;46:3630-6. - PubMed
1. Earl J, Rico D, Carrillo-de-Santa-Pau E, et al. The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies. BMC genomics 2015;16:403. 10.1186/s12864-015-1450-3 - DOI - PMC - PubMed
1. Booth C, Harnden P, Trejdosiewicz LK, et al. Stromal and vascular invasion in an human in vitro bladder cancer model. Lab Invest 1997;76:843-57. - PubMed
1. Ringuette Goulet C, Bernard G, Chabaud S, et al. Tissue-engineered human 3D model of bladder cancer for invasion study and drug discovery. Biomaterials 2017;145:233-41. 10.1016/j.biomaterials.2017.08.041 - DOI - PubMed
1. John BA, Said N. Insights from animal models of bladder cancer: recent advances, challenges, and opportunities. Oncotarget 2017;8:57766-81. 10.18632/oncotarget.17714 - DOI - PMC - PubMed